QR Code

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer

Abstract Introduction Cabazitaxel multiple rechallenges may be a treatment option in heavily pretreated patients with metastatic castration‐resistant prostate cancer (mCRPC) who had a good initial response to cabazitaxel and who are still fit to receive it. Our objective was to assess the efficacy a...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Cedric Pobel, Edouard Auclin, Diego Teyssonneau, Brigitte Laguerre, Mathilde Cancel, Elouen Boughalem, Johanna Noel, Pierre Emmanuel Brachet, Denis Maillet, Philippe Barthelemy, Carole Helissey, Constance Thibault, Stéphane Oudard
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Wiley 2021-09-01
Rangatū:Cancer Medicine
Ngā marau:
prostate cancer
chemotherapy
metastasis
cancer management
urological oncology
Urunga tuihono:https://doi.org/10.1002/cam4.4172
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite